Kroger Pharmacy vs Idexx Laboratories
Side-by-side comparison of AI visibility scores, market position, and capabilities
Kroger-owned in-store pharmacy chain with 2,200 locations in supermarket banners; prescription services integrated with grocery loyalty program competing with CVS and Walgreens.
About
Kroger Pharmacy is the pharmacy division of The Kroger Co., operating approximately 2,200 in-store pharmacies within Kroger supermarkets and Kroger-owned banner stores (Fred Meyer, King Soopers, Ralphs, Harris Teeter, Smith's, and others) across the United States — making it one of the largest pharmacy chains in the country. Part of Kroger (NYSE: KR), the nation's largest pure-play supermarket chain with approximately $150 billion in annual revenue, Kroger Pharmacy benefits from the combination of convenient supermarket co-location and Kroger's pharmaceutical purchasing scale.\n\nKroger Pharmacy provides prescription filling, immunization services, medication therapy management, and specialty pharmacy for complex medications. The pharmacy integrates with Kroger's loyalty program (Kroger Plus Card) to provide fuel points for pharmacy purchases and to connect prescription refill reminders with grocery shopping behavior. Kroger's OptUP nutrition scoring and health programs connect pharmacy and grocery to support customer health goals.\n\nIn 2025, Kroger Pharmacy competes with CVS Health, Walgreens, Walmart Pharmacy, and mail-order pharmacies for prescription market share. The retail pharmacy sector faces significant pressure from PBM reimbursement cuts and the shift to 90-day mail-order supply, which has forced pharmacy closures across the industry. Kroger's merger with Albertsons (blocked by FTC in February 2024) would have significantly expanded Kroger's pharmacy network, but the blocked merger leaves Kroger competing at current scale. The 2025 strategy focuses on integrating pharmacy into Kroger's digital health ecosystem, expanding specialty pharmacy capabilities, and leveraging Kroger Health data analytics for population health management programs.
Veterinary diagnostics leader with $3.81B FY2024 revenue; 130,000+ analyzer installed base; AI-powered inVue Dx digital cytology; VetConnect data platform; pet humanization tailwind.
About
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headquartered. The company trades on Nasdaq (IDXX) and reported $3.81 billion in revenues for FY2024, maintaining its dominant position in point-of-care veterinary diagnostics through an installed base of over 130,000 Catalyst chemistry analyzers, ProCyte hematology systems, and SNAP rapid assay devices deployed in veterinary clinics worldwide. CEO Jay Mazelsky has continued IDEXX's expansion into AI-powered diagnostics and digital pathology, building on over four decades of veterinary-specific product development.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Kroger Pharmacy vs
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.